Soluble amyloid-β, effect on cerebral arteriolar regulation and vascular cells

Molecular Neurodegeneration

Volumn 5, Issue 1, 2010, Pages

  Dietrich, Hans H ^a   Xiang, Chuanxi ^a   Han, Byung H ^a   Zipfel, Gregory J ^a   Holtzman, David M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN ANTIBODY; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; REACTIVE OXYGEN METABOLITE;

AGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY DIAMETER; ARTERY DILATATION; ARTERY TONE; ARTICLE; BLOOD VESSEL REACTIVITY; CELLULAR STRESS RESPONSE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; LONG TERM EXPOSURE; MALE; MIDDLE CEREBRAL ARTERY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN FUNCTION; RAT; UPREGULATION; VASCULAR AMYLOIDOSIS;

ANIMALIA; MUS; RATTUS; RODENTIA;

EID: 77950671610     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-5-15     Document Type: Article

References (47)

1. Alzheimer's disease: genes, proteins, and therapy. DJ Selkoe, Physiol Rev 2001 81 741 766 11274343
2. Intramembrane proteolysis by presenilins. H Steiner C Haass, Nat Rev Mol Cell Biol 2000 1 217 224 10.1038/35043065 11252897
3. Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study. A Ruitenberg HT den SL Bakker JC van Swieten PJ Koudstaal A Hofman MM Breteler, Ann Neurol 2005 57 789 794 10.1002/ana.20493 15929050
4. Increased susceptibility to ischemic brain damage in transgenic mice overexpressing the amyloid precursor protein. F Zhang C Eckman S Younkin KK Hsiao C Iadecola, J Neurosci 1997 17 7655 7661 9315887
5. Abeta 1-40-related reduction in functional hyperemia in mouse neocortex during somatosensory activation. K Niwa L Younkin C Ebeling SK Turner D Westaway S Younkin KH Ashe GA Carlson C Iadecola, Proc Natl Acad Sci USA 2000 97 9735 9740 10.1073/pnas.97.17.9735 10944232
6. Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor protein. K Niwa K Kazama L Younkin SG Younkin GA Carlson C Iadecola, Am J Physiol Heart Circ Physiol 2002 283 315 H323 12063304
7. Nilvadipine antagonizes both Abeta vasoactivity in isolated arteries, and the reduced cerebral blood flow in APPsw transgenic mice. D Paris A Quadros J Humphrey N Patel R Crescentini F Crawford M Mullan, Brain Res 2004 999 53 61 10.1016/j.brainres.2003.11.061 14746921
8. Cerebrovascular dysfunction in amyloid precursor protein transgenic mice: contribution of soluble and insoluble amyloid-beta peptide, partial restoration via gamma-secretase inhibition. BH Han ML Zhou F Abousaleh RP Brendza HH Dietrich J Koenigsknecht-Talboo JR Cirrito E Milner DM Holtzman GJ Zipfel, J Neurosci 2008 28 13542 13550 10.1523/JNEUROSCI.4686-08.2008 19074028
9. Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy. HK Shin PB Jones M Garcia-Alloza L Borrelli SM Greenberg BJ Bacskai MP Frosch BT Hyman MA Moskowitz C Ayata, Brain 2007 130 2310 2319 10.1093/brain/awm156 17638859 (Pubitemid 47327629)
10. Structural and functional disruption of vascular smooth muscle cells in a transgenic mouse model of amyloid angiopathy. R Christie M Yamada M Moskowitz B Hyman, Am J Pathol 2001 158 1065 1071 11238054
11. Soluble Alzheimers beta-amyloid constricts the cerebral vasculature in vivo. Z Suo J Humphrey A Kundtz F Sethi A Placzek F Crawford M Mullan, Neurosci Lett 1998 257 77 80 10.1016/S0304-3940(98)00814-3 9865931
12. A-peptides enhance vasoconstriction in cerebral circulation. K Niwa VA Porter K Kazama D Cornfield GA Carlson C Iadecola, Am J Physiol Heart Circ Physiol 2001 281 2417 H2424 11709407
13. Vasoactive effects of A beta in isolated human cerebrovessels and in a transgenic mouse model of Alzheimer's disease: role of inflammation. D Paris J Humphrey A Quadros N Patel R Crescentini F Crawford M Mullan, Neurol Res 2003 25 642 651 10.1179/016164103101201940 14503019
14. Cerebrovascular endothelial dysfunction mediated by beta-amyloid. T Thomas C McLendon ET Sutton G Thomas, Neuroreport 1997 8 1387 1391 10.1097/00001756-199704140-00014 9172141 (Pubitemid 27242542)
15. beta-Amyloid induces cerebrovascular endothelial dysfunction in the rat brain. JM Price ET Sutton A Hellermann T Thomas, Neurol Res 1997 19 534 538 9329032
16. Mechanisms of soluble beta-amyloid impairment of endothelial function. MT Gentile C Vecchione A Maffei A Aretini G Marino R Poulet L Capobianco G Selvetella G Lembo, J Biol Chem 2004 279 48135 48142 10.1074/jbc.M407358200 15319431
17. Role of peroxynitrite in the vasoactive and cytotoxic effects of Alzheimer's beta-amyloid1-40 peptide. D Paris TA Parker T Town Z Suo C Fang J Humphrey F Crawford M Mullan, Exp Neurol 1998 152 116 122 10.1006/exnr.1998.6828 9682018
18. NADPH-oxidase-derived reactive oxygen species mediate the cerebrovascular dysfunction induced by the amyloid beta peptide. L Park J Anrather P Zhou K Frys R Pitstick S Younkin GA Carlson C Iadecola, J Neurosci 2005 25 1769 1777 10.1523/JNEUROSCI.5207-04.2005 15716413
19. Exogenous A beta1-40 reproduces cerebrovascular alterations resulting from amyloid precursor protein overexpression in mice. K Niwa GA Carlson C Iadecola, J Cereb Blood Flow Metab 2000 20 1659 1668 10.1097/00004647-200012000- 00005 11129782
20. Physiological levels of beta-amyloid induce cerebral vessel dysfunction and reduce endothelial nitric oxide production. JM Price X Chi G Hellermann ET Sutton, Neurol Res 2001 23 506 512 10.1179/016164101101198758 11474807
21. RAGE (yin) versus LRP (yang) balance regulates alzheimer amyloid beta-peptide clearance through transport across the blood-brain barrier. R Deane Z Wu BV Zlokovic, Stroke 2004 35 2628 2631 10.1161/01.STR.0000143452.85382.d1 15459432
22. A study of rat intracerebral arterioles: methods, morphology, and reactivity. RG Dacey Jr BR Duling, Am J Physiol 1982 243 598 H606 7124967
23. Functional heterogeneity of endothelial P2 purinoceptors in the cerebrovascular tree of the rat. JP You TD Johnson SP Marrelli RM Bryan Jr, Am J Physiol Heart Circ Physiol 1999 277 893 H900
24. Mechanism of ATP-induced local and conducted vasomotor responses in isolated rat cerebral penetrating arterioles. HH Dietrich T Horiuchi C Xiang K Hongo JR Falck RG Dacey Jr, J Vasc Res 2009 46 253 264 10.1159/000167273 18984964
25. Rat cerebral microvascular smooth muscle cells in culture. CA Diglio P Grammas F Giacomelli J Wiener, J Cell Physiol 1986 129 131 141 10.1002/jcp.1041290202 3533958
26. Transformation of rat cerebral endothelial cells by rous sarcoma virus. CA Diglio DE Wolfe P Meyers, J Cell Biol 1983 97 15 21 10.1083/jcb.97.1.15 6134735
27. 2u receptor-mediated release of endothelium-derived relaxing factor nitric oxide and endothelium-derived hyperpolarizing factor from cerebrovascular endothelium in rats. JP You TD Johnson SP Marrelli JV Mombouli RM Bryan Jr, Stroke 1999 30 1125 1132 10229754
28. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. K Hsiao P Chapman S Nilsen C Eckman Y Harigaya S Younkin F Yang G Cole, Science 1996 274 99 102 10.1126/science.274.5284.99 8810256
29. Apolipoprotein E markedly facilitates age-dependent cerebral amyloid angiopathy and spontaneous hemorrhage in amyloid precursor protein transgenic mice. JD Fryer JW Taylor RB DeMattos KR Bales SM Paul M Parsadanian DM Holtzman, J Neurosci 2003 23 7889 7896 12944519
30. Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model. JC Dodart KR Bales KS Gannon SJ Greene RB DeMattos C Mathis CA DeLong S Wu X Wu DM Holtzman, et al. Nat Neurosci 2002 5 452 457 11941374
31. Maximizing the potential of plasma amyloid-beta as a diagnostic biomarker for Alzheimer's disease. ES Oh JC Troncoso SM Fangmark Tucker, Neuromolecular Med 2008 10 195 207 10.1007/s12017-008-8035-0 18543125
32. SRF and myocardin regulate LRP-mediated amyloid-beta clearance in brain vascular cells. RD Bell R Deane N Chow X Long A Sagare I Singh JW Streb H Guo A Rubio W Nostrand, et al. Nat Cell Biol 2008 19098903
33. Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43). SA Gravina L Ho CB Eckman KE Long L Otvos Jr LH Younkin N Suzuki SG Younkin, J Biol Chem 1995 270 7013 7016 10.1074/jbc.270.13. 7013 7706234
34. Abeta42 is essential for parenchymal and vascular amyloid deposition in mice. E McGowan F Pickford J Kim L Onstead J Eriksen C Yu L Skipper MP Murphy J Beard P Das, et al. Neuron 2005 47 191 199 10.1016/j.neuron.2005.06.030 16039562
35. Superoxide free radical and intracellular calcium mediate A beta(1-42) induced endothelial toxicity. Z Suo C Fang F Crawford M Mullan, Brain Res 1997 762 144 152 10.1016/S0006-8993(97)00383-1 9262168
36. Analysis of purine- and pyrimidine-induced vascular responses in the isolated rat cerebral arteriole. T Horiuchi HH Dietrich S Tsugane RG Dacey Jr, American Journal of Physiology - Heart & Circulatory Physiology 2001 280 767 H776
37. Pharmacology of P2X channels. JR Gever DA Cockayne MP Dillon G Burnstock AP Ford, Pflugers Arch 2006 452 513 537 10.1007/s00424-006-0070-9 16649055
38. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. R Deane YS Du RK Submamaryan B LaRue S Jovanovic E Hogg D Welch L Manness C Lin J Yu, et al. Nat Med 2003 9 907 913 10.1038/nm890 12808450
39. Active and passive immunotherapy for neurodegenerative disorders. DL Brody DM Holtzman, Annu Rev Neurosci 2008 31 175 193 10.1146/annurev.neuro.31. 060407.125529 18352830
40. Animal model of Alzheimer-like vascular pathology and inflammatory reaction. J Rhodin T Thomas M Bryant ET Sutton, Ann N Y Acad Sci 2000 903 345 352 10.1111/j.1749-6632.2000.tb06385.x 10818524
41. Amyloid-beta peptide decreases glutamate uptake in cultured astrocytes: involvement of oxidative stress and mitogen-activated protein kinase cascades. M Matos E Augusto CR Oliveira P Agostinho, Neuroscience 2008 156 898 910 10.1016/j.neuroscience.2008.08.022 18790019
42. Effects of beta-amyloid on rat neuromicrovascular endothelial cells cultured in vitro. M Folin S Baiguera M Tommasini D Guidolin MT Conconi CE De GG Nussdorfer PP Parnigotto, Int J Mol Med 2005 15 929 935 15870895
43. Toxicity of various amyloid beta peptide species in cultured human blood-brain barrier endothelial cells: increased toxicity of dutch-type mutant. PB Eisenhauer RJ Johnson JM Wells TA Davies RE Fine, J Neurosci Res 2000 60 804 810 10.1002/1097-4547(20000615)60:6<804::AID-JNR13>3.0.CO;2-1 10861793
44. Abeta does not induce oxidative stress in human cerebrovascular smooth muscle cells. SS Jung WE Van Nostrand, Neuroreport 2002 13 1309 1312 10.1097/00001756-200207190-00019 12151793
45. Hereditary cerebral hemorrhage with amyloidosis-Dutch type. M Maat-Schieman R Roos S van Duinen, Neuropathology 2005 25 288 297 10.1111/j.1440-1789.2005.00631.x 16382777
46. Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis. MC Herzig DT Winkler P Burgermeister M Pfeifer E Kohler SD Schmidt S Danner D Abramowski C Sturchler-Pierrat K Burki, et al. Nat Neurosci 2004 7 954 960 10.1038/nn1302 15311281
47. Structural classification of toxic amyloid oligomers. CG Glabe, J Biol Chem 2008 283 29639 29643 10.1074/jbc.R800016200 18723507